←
Alejandro Aguilera Castrejon1,289 posts
Alejandro Aguilera Castrejon avatar

Alejandro Aguilera Castrejon

@AlejandroAgCa

🇲🇽 Ex utero embryogenesis and stem-cell embryo models. 1st gen scientist. Group Leader at 4DCP, HHMI Janelia, USA.

◷ Joined March 2011▧ 5 Photos and videos
Development avatar
⟳ Alejandro Aguilera Castrejon retweeted
Development@Dev_journal·Oct 27

Mechano-metabolic control of multicellular morphogenesis Bodineau, Pourquié, Mongera & co discuss how research into mechano-metabolic feedback loops during multicellular morphogenesis can drive major advances in our understanding of #DevBio. doi.org/10.1242/dev.204876

Post attachment
ISSCR avatar
⟳ Alejandro Aguilera Castrejon retweeted
ISSCR@ISSCR·Oct 19

The ISSCR was proud to collaborate with the @AllenInstitute and the @SocDevBio on the inaugural Stem Cell & Developmental Biology Early Career Symposium. Read more about this collaboration: alleninstitute.org/news/firs…

Jay Shendure avatar
⟳ Alejandro Aguilera Castrejon retweeted
Jay Shendure@JShendure·Oct 8

Exciting day for DNA Typewriter w/ 2 papers from the lab & SeaHub out today :) 1. Mouse lineage from E0 to E13.5 science.org/doi/10.1126/scie… 2. A fluctuation test for gastruloid heterogeneity cell.com/cell/fulltext/S0092… Paper #1 covered in quoted thread. More on paper #2 here. 1/n

Thrilled to post thread re: new single-cell lineage of mouse embryo reconstructed w/ DNA Typewriter. One animal, zygote to late organogenesis (E13.5). Tree has 1,340,794 transcriptionally profiled, annotated tips (cells), 1,142,588 dated internal nodes, rooted at zygote 1/n

The Nobel Prize avatar
⟳ Alejandro Aguilera Castrejon retweeted
The Nobel Prize@NobelPrize·Oct 5

Peter Hegemann and Georg Nagel – awarded the 2026 medicine prize – discovered a remarkable protein, channelrhodopsin, in a single-celled alga. Hegemann wondered how Chlamydomonas, a single-celled alga, is able to swim towards a light source. In the early 2000s, he and Georg Nagel discovered channelrhodopsin, an algal protein with unique properties, found on the surface of the cell. When it is illuminated by blue light, a channel opens through the protein. Charged ions then flow into the cell, creating an electrical impulse. They found that regardless of which cell they put the protein in, those cells became light sensitive. #NobelPrize

Post attachment
The Nobel Prize avatar
⟳ Alejandro Aguilera Castrejon retweeted
The Nobel Prize@NobelPrize·Oct 5

BREAKING NEWS The 2026 #NobelPrize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”

Post attachment
Michael Lin, MD PhD 🧬 avatar
⟳ Alejandro Aguilera Castrejon retweeted
Michael Lin, MD PhD 🧬@michaelzlin·Sep 28

Today our lab is excited to share a new study in Cell: “Non-invasive control of gene editing in vivo by photoswitchable Cas12f and focused ultrasound.” We engineered a compact CRISPR system that can be activated at specific locations in the body using focused ultrasound (🧵)

Post attachment
Adam Rochussen avatar
⟳ Alejandro Aguilera Castrejon retweeted
Adam Rochussen@AdamRochussen·Sep 25

This isn’t just anecdotal. I scraped bibliometric data from Nobel laureates and computed the disruption index of their top papers from each 5-year bin of their publication records. Disruptiveness declines ~linearly with age!

Post attachment
Meng Zhu avatar
⟳ Alejandro Aguilera Castrejon retweeted
Meng Zhu@zhumeng123·Sep 24

Two years since the 1st submission, our work on limb heterochrony is finally out! 🎉🎊@CellCellPress Delayed hindlimb dev vs forelimb is a widely conserved trait in mammals. We show that maternal O2 regulates this phenotype 👉🏻 shorturl.at/MGrwl

Lucas Harrington avatar
⟳ Alejandro Aguilera Castrejon retweeted
Lucas Harrington@CRISPR_LuCas·Sep 23

As someone who did this kind of genome mining work during my PhD, some thoughts on this Anthropic announcement: First, the very simplified version of what they did is that they noticed two genes (one known, one new) sitting next to a weird repeating piece of DNA. More specifically, they described an unusual reverse transcriptase (RT) associated with a repetitive DNA array and an unknown accessory protein. This kind of process was used to understand CRISPR back in 2002 and was key to the gene editing tools we use today. To put this into context, though, people have been finding RTs associated with CRISPR arrays since 2008, and this general kind of genome-neighborhood mining has been used to discover new biological systems for decades. The basic genome-mining strategy is well established, and there are now mature tools and published pipelines for doing much of this. There are papers that discover and experimentally validate dozens of new systems using this approach in a single study. Doing it in bacteriophage genomes is also nothing new (eg CasPhi). Finding a weird cluster of genes and repeats is often the easy part. The hard part, and where the real discoveries come from, is figuring out what the system actually does. Eg for the bridge-RNA discovery in 2024 from @arcinstitute or the discovery of CasPhi in 2020 from @DoudnaJennifer they figured out the pieces of the system and the rules for what makes it work so it can be used. Anthropic does not yet know what this does. They’ve shown that the repeat array produces RNAs, but not what those RNAs do, what the RT does with them, or whether the system has any of the programmable properties that make the CRISPR comparison justified. I’m genuinely rooting for all of the frontier labs to seriously get into biological discovery, and I’m excited about what comes out of it. But announcing these very early, incremental findings with the framing of a major discovery doesn’t help. I’d much rather they set the bar high now, so that when an AI actually discovers a fundamentally new biological mechanism, everyone appreciates how big a deal it is.

Claude has discovered a previously unknown enzyme system hidden in the DNA of bacteriophages. Beside the enzyme’s gene sits a long array of repeating DNA—a structure that looks somewhat similar to CRISPR. We don’t yet understand what this system does, but only a handful of known systems share its features, and all of them are able to cut, copy, and paste DNA. Historically, the discovery of such programmable systems has helped revolutionize medicine. CRISPR, for instance, is now the foundation of genetic medicines. But it will take much more work to learn what this system does, and whether it can be put to similar use. Read more: anthropic.com/news/claude-di…

Zane Koch avatar
⟳ Alejandro Aguilera Castrejon retweeted
Zane Koch@zanehkoch·Sep 18

Science – debatably the #1 journal in the world – published a paper on a "virtual biotech" AI system this week but the authors never even test if it works well! all the evidence for its performance is 3 anecdotes the paper has no benchmark scores, no baselines, no replicates

Post attachment
Sergiu P. Pasca avatar
⟳ Alejandro Aguilera Castrejon retweeted
Sergiu P. Pasca@Sergiu_P_Pasca·Sep 16

Today in @Nature, we report a new approach to studying human brain development and modeling disease in vivo. Human neural #assembloids and #organoids have opened new ways to study development in vitro, but they also have important limitations. Transplantation can provide a more physiological environment, yet human cortical cells then develop within a rodent brain that matures much faster, constraining their growth and integration. To address some of these limitations and obtain more advanced functional readouts relevant to disease biology, we generated #apallial mice, in which ~98% of the cortex and hippocampus fail to form, creating space for transplanted human cortical organoids to grow and integrate extensively. We call these #xenocortical mice (XCX). Nearly 7 years in the making. Congratulations to an extraordinary team and wonderful collaborators! Link to the article below 👇

Post attachment
Martin Pera avatar
⟳ Alejandro Aguilera Castrejon retweeted
Martin Pera@martinperaJAX·Sep 15

Abdelbaki, A., McCarthy, A., Karsa, A. et al. Live imaging of late-stage preimplantation human embryos reveals de novo mitotic errors. Nat Biotechnol 44, 1482–1492 (2026). doi.org/10.1038/s41587-025-0…